for risk-based screening of diabetic retinopathy in people with newly-diagnosed

,

[1]  M. Kocabora,et al.  Serum and Aqueous Concentrations of Inflammatory Markers in Diabetic Macular Edema , 2016, Ocular immunology and inflammation.

[2]  S. Hosseini,et al.  Iranian risk model as a predictive tool for retinopathy in patients with type 2 diabetes. , 2015, Canadian journal of diabetes.

[3]  C. Tack,et al.  IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance. , 2015, Cytokine.

[4]  T. Wong,et al.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss , 2015, Eye and Vision.

[5]  H. Hammes,et al.  Risk Factors for Retinopathy and DME in Type 2 Diabetes—Results from the German/Austrian DPV Database , 2015, PloS one.

[6]  T. Peto,et al.  Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS) , 2015, Diabetologia.

[7]  C. Costagliola,et al.  Diabetic Retinopathy: Vascular and Inflammatory Disease , 2015, Journal of diabetes research.

[8]  J. J. Wang,et al.  Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[9]  V. Mohan,et al.  Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--3. , 2015, Diabetes technology & therapeutics.

[10]  B. Hawkins,et al.  Blood pressure control for diabetic retinopathy. , 2015, The Cochrane database of systematic reviews.

[11]  A. Adams,et al.  Male–Female Differences in Diabetic Retinopathy? , 2015, Current eye research.

[12]  J. J. Wang,et al.  Relative Importance and Contribiton of Risk Factors for Diabetic Retinopathy and Macular Edema , 2014 .

[13]  L. Aiello.  Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.

[14]  J. Manson,et al.  Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. , 2013, JAMA ophthalmology.

[15]  S. Sivaprasad,et al.  The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: the South London Diabetes cohort (SOUL-D) , 2013, Diabetologia.

[16]  H. Yamashita,et al.  Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. , 2013, Ophthalmology.

[17]  C. Cheung,et al.  Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy , 2012, Molecular vision.

[18]  S. Sivaprasad,et al.  Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK) , 2012, PloS one.

[19]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[20]  A. Montgomery,et al.  Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial , 2011, The Lancet.

[21]  Kamlesh Khunti,et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.

[22]  I. Chatziralli,et al.  Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2 , 2010, BMC Research Notes.

[23]  G. Lacraz,et al.  Islet Endothelial Activation and Oxidative Stress Gene Expression Is Reduced by IL-1Ra Treatment in the Type 2 Diabetic GK Rat , 2009, PloS one.

[24]  A. Smit,et al.  Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10) , 2009, PloS one.

[25]  D. de Zeeuw,et al.  First morning voids are more reliable than spot urine samples to assess microalbuminuria. , 2009, Journal of the American Society of Nephrology : JASN.

[26]  V. Mohan,et al.  Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4 , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[27]  R. Klein,et al.  Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study. , 2007, Investigative ophthalmology & visual science.

[28]  E. Agrón,et al.  Serum inflammatory markers in diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[29]  L. Bouter,et al.  Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. , 2003, Diabetes care.

[30]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[31]  J. Nagy,et al.  Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[32]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[33]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[34]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[35]  R. Klein,et al.  Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses , 1993, Diabetologia.

[36]  Wen-Chuan Wu,et al.  Dyslipidemia and diabetic retinopathy. , 2013, The review of diabetic studies : RDS.

[37]  L. Aiello,et al.  Retinopathy in diabetes. , 2004, Diabetes care.

[38]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.